Co-authors

Researcher identifiers

Export Publications

Export the displayed publications:
Number of documents

14

Olivier Colliot - Research Director at CNRS - ARAMIS Lab (CNRS/INRIA/Inserm/UPMC)


Research Director at CNRS

 

Head of the ARAMIS Lab, a joint team between CNRSInriaInserm and University Pierre and Marie Curie at the Brain and Spine Institute (ICM), in co-direction with Didier Dormont.

 


"Harald Hampel"   

Journal articles10 documents

  • Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, et al.. Reduction of recruitment costs in preclinical AD trials. Validation of automatic pre-screening algorithm for brain amyloidosis. Statistical Methods in Medical Research, SAGE Publications, 2019, pp.096228021882303. ⟨10.1177/0962280218823036⟩. ⟨hal-01964942v2⟩
  • Bruno Dubois, Stéphane Epelbaum, Francis Nyasse, Hovagim Bakardjian, Geoffroy Gagliardi, et al.. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurology, Elsevier, 2018, 17 (4), pp.335 - 346. ⟨10.1016/S1474-4422(18)30029-2⟩. ⟨hal-01777834⟩
  • Harald Hampel, Nicola Toschi, Claudio Babiloni, Filippo Baldacci, Keith Black, et al.. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. Journal of Alzheimer's Disease, IOS Press, 2018, 64 (s1), pp.S47 - S105. ⟨10.3233/jad-179932⟩. ⟨hal-01910402⟩
  • Thomas Jacquemont, Fabrizio de Vico Fallani, Anne Bertrand, Stéphane Epelbaum, Alexandre Routier, et al.. Amyloidosis and neurodegeneration result in distinct structural connectivity patterns in mild cognitive impairment. Neurobiology of Aging, Elsevier, 2017, ⟨10.1016/j.neurobiolaging.2017.03.023⟩. ⟨hal-01518785⟩
  • Enrica Cavedo, Michel J Grothe, Olivier Colliot, Simone Lista, Marie Chupin, et al.. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease. Scientific Reports, Nature Publishing Group, 2017, 7 (1), pp.11706. ⟨10.1038/s41598-017-09780-3⟩. ⟨hal-01589622⟩
  • Stefan J Teipel, Enrica Cavedo, Michel J Grothe, Simone Lista, Samantha Galluzzi, et al.. Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease. Neuropharmacology, Elsevier, 2016, 108, pp.128-35. ⟨hal-01372417⟩
  • Enrica Cavedo, Bruno Dubois, Olivier Colliot, Simone Lista, Bernard Croisile, et al.. Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease. Journal of Clinical Psychiatry, Physicians Postgraduate Press, 2016, ⟨10.4088/JCP.15m10413 ⟩. ⟨hal-01388951⟩
  • Bruno Dubois, Marie Chupin, Harald Hampel, Simone Lista, Enrica Cavedo, et al.. Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease. Alzheimer's and Dementia, Elsevier, 2015, 11 (9), pp.1041-1049. ⟨10.1016/j.jalz.2014.10.003⟩. ⟨hal-01249861⟩
  • Harald Hampel, Simone Lista, Stefan J Teipel, Francesco Garaci, Robert Nisticò, et al.. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. Biochemical Pharmacology, Elsevier, 2014, pp.426-49. ⟨hal-01098832⟩
  • Enrica Cavedo, Simone Lista, Zaven S Khachaturian, Paul S Aisen, Philippe Amouyel, et al.. The road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations. Journal of Prevention of Alzheimer’s Disease, 2014, 1 (3), pp.181-202. ⟨10.14283/jpad.2014.32⟩. ⟨hal-01098836⟩

Conference papers4 documents

  • Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, et al.. Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trials. Multimodal Learning for Clinical Decision Support, Sep 2017, Quebec City, Canada. ⟨hal-01578422⟩
  • Manon Ansart, Stéphane Epelbaum, Olivier Colliot, Didier Dormont, Bruno Dubois, et al.. Selection of amyloid positive pre-symptomatic subjects using automatic analysis of neuropsychological and MRI data for cost effective inclusion procedures in clinical trials. Clinical Trials for Alzheimer's Disease, Nov 2017, Boston, United States. pp.295. ⟨hal-02098434v2⟩
  • Alexandre Morin, Jorge Samper-Gonzales, Anne Bertrand, Enrica Cavedo, Simone Lista, et al.. Accuracy of MRI classification algorithms in a tertiary memory center clinical routine cohort. AAIC 2017 - Alzheimer's Association International Conference, Jul 2017, London, United Kingdom. pp.P772-P774, ⟨10.1016/j.jalz.2017.06.1034⟩. ⟨hal-02192444⟩
  • Anne Bertrand, Stephane Epelbaum, Marie-Odile Habert, Harald Hampel, Hovagim Bakardjian, et al.. The INSIGHT cohort: baseline analysis of structural MR imaging in asymptomatic subjects at risk for Alzheimer's disease. AAIC, Jul 2016, Toronto, Canada. ⟨10.1016/j.jalz.2016.06.612⟩. ⟨hal-01439571⟩